Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Dunbar

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 26, 1998
Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's diseaseD A Shear, J Dong, C D Gundy, et al.
Neuropharmacology|June 30, 2004
NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian ratsR H Wessell, S M Ahmed, F S Menniti, et al.
Experimental Neurology|May 30, 1998
Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze taskD A Shear, J Dong, K L Haik-Creguer, et al.
Neuroscience|August 23, 2015
In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 miceM-S Song, C R Learman, K-C Ahn, et al.
Journal of Neuroinflammation|January 7, 2019
Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10 promotes alternative inflammatory response in rat model of traumatic brain injuryS T Peruzzaro, M M M Andrews, A Al-Gharaibeh, et al.
Restorative Neurology and Neuroscience|August 2, 2013
Bone-marrow-derived mesenchymal stem cells attenuate cognitive deficits in an endothelin-1 rat model of strokeS A Lowrance, K D Fink, A Crane, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 22, 2012
Assessing the potential clinical utility of transplantations of neural and mesenchymal stem cells for treating neurodegenerative diseasesLaurent Lescaudron, C Boyer, Virginie Bonnamain, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 26, 1998
Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's diseaseD A Shear, J Dong, C D Gundy, et al.
Neuropharmacology|June 30, 2004
NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian ratsR H Wessell, S M Ahmed, F S Menniti, et al.
Experimental Neurology|May 30, 1998
Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze taskD A Shear, J Dong, K L Haik-Creguer, et al.
Neuroscience|August 23, 2015
In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 miceM-S Song, C R Learman, K-C Ahn, et al.
Journal of Neuroinflammation|January 7, 2019
Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10 promotes alternative inflammatory response in rat model of traumatic brain injuryS T Peruzzaro, M M M Andrews, A Al-Gharaibeh, et al.
Restorative Neurology and Neuroscience|August 2, 2013
Bone-marrow-derived mesenchymal stem cells attenuate cognitive deficits in an endothelin-1 rat model of strokeS A Lowrance, K D Fink, A Crane, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 22, 2012
Assessing the potential clinical utility of transplantations of neural and mesenchymal stem cells for treating neurodegenerative diseasesLaurent Lescaudron, C Boyer, Virginie Bonnamain, et al.
Pageof 2